Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD CME Group Education AD Bank of England Statistics AD Investing.com Markets AD LSEG Data
City & Markets

Xylem Consensus Price Target Lowered by 12.92% to $126.34

City noticeboard, Trade Hub UK (2026-11-02): The average one-year price target for Xylem (NYSE:XYL) (BIT:1XYL) has been revised to $126.34 / share. This is a decrease of 12.92% from the prior estimate of… Primary source: original at Nasdaq (nasdaq.com).

By Nasdaq

Xylem Consensus Price Target Lowered by 12.92% to $126.34

The average one-year price target for Xylem (NYSE:XYL) (BIT:1XYL) has been revised to $126.34 / share. This is a decrease of 12.92% from the prior estimate of $145.08 dated October 20, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not constitut

Read at source

Read also
  1. Medical Properties Trust Consensus Price Target Lowered by 11.38% to $4.63
  2. Sino Biopharmaceutical Limited - Depositary Receipt Consensus Price Target Decreased by 15.14% to $21.83
  3. Surgery Partners Consensus Price Target Increased by 15.45% to $22.61
  4. Cadiz Consensus Price Target Increased by 29.17% to $10.54
  5. AEVEX Consensus Price Target Decreased by 12.28% to $25.61

Source: Nasdaq